Format

Send to

Choose Destination
BMC Cancer. 2004 Nov 23;4:84.

SMAC is expressed de novo in a subset of cervical cancer tumors.

Author information

1
Subdirección de Investigación Básica. Instituto Nacional de Cancerología, México, DF MEXICO. maggiec73@hotmail.com <maggiec73@hotmail.com>

Abstract

BACKGROUND:

Smac/Diablo is a recently identified protein that is released from mitochondria after apoptotic stimuli. It binds IAPs, allowing caspase activation and cell death. In view of its activity it might participate in carcinogenesis. In the present study, we analyzed Smac expression in a panel of cervical cancer patients.

METHODS:

We performed semi quantitative RT-PCR on 41 cervical tumor and 6 normal tissue samples. The study included 8 stage I cases; 16 stage II; 17 stage III; and a control group of 6 samples of normal cervical squamous epithelial tissue.

RESULTS:

Smac mRNA expression was below the detection limit in the normal cervical tissue samples. In contrast, 13 (31.7%) of the 41 cervical cancer biopsies showed detectable levels of this transcript. The samples expressing Smac were distributed equally among the stages (5 in stage I, 4 in stage II and 4 in stage III) with similar expression levels. We found no correlation between the presence of Smac mRNA and histology, menopause, WHO stage or disease status.

CONCLUSIONS:

Smac is expressed de novo in a subset of cervical cancer patients, reflecting a possible heterogeneity in the pathways leading to cervical cancer. There was no correlation with any clinical variable.

PMID:
15560849
PMCID:
PMC535940
DOI:
10.1186/1471-2407-4-84
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center